275 related articles for article (PubMed ID: 18324737)
1. Enhancement of cell-specific transgene expression from a Tet-Off regulatory system using a transcriptional amplification strategy in the rat brain.
Liu B; Wang S; Brenner M; Paton JF; Kasparov S
J Gene Med; 2008 May; 10(5):583-92. PubMed ID: 18324737
[TBL] [Abstract][Full Text] [Related]
2. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
[TBL] [Abstract][Full Text] [Related]
3. Increased utility in the CNS of a powerful neuron-specific tetracycline-regulatable adenoviral system developed using a post-transcriptional enhancer.
Lee YB; Cosgrave AS; Glover CP; Bienemann A; Heywood D; Hobson RJ; Uney JB
J Gene Med; 2005 May; 7(5):576-83. PubMed ID: 15580589
[TBL] [Abstract][Full Text] [Related]
4. GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain.
Liu BH; Yang Y; Paton JF; Li F; Boulaire J; Kasparov S; Wang S
Mol Ther; 2006 Dec; 14(6):872-82. PubMed ID: 16904943
[TBL] [Abstract][Full Text] [Related]
5. Development of a doxycycline-inducible lentiviral plasmid with an instant regulatory feature.
Yang T; Burrows C; Park JH
Plasmid; 2014 Mar; 72():29-35. PubMed ID: 24727543
[TBL] [Abstract][Full Text] [Related]
6. Promoter cross-talk affects the inducible expression of intronic shRNAs from the tetracycline response element.
Park SK; Hwang BJ; Kee Y
Genes Genomics; 2019 Apr; 41(4):483-490. PubMed ID: 30656518
[TBL] [Abstract][Full Text] [Related]
7. Cell-type-specific and regulatable transgenesis in the adult brain: adenovirus-encoded combined transcriptional targeting and inducible transgene expression.
Smith-Arica JR; Morelli AE; Larregina AT; Smith J; Lowenstein PR; Castro MG
Mol Ther; 2000 Dec; 2(6):579-87. PubMed ID: 11124058
[TBL] [Abstract][Full Text] [Related]
8. Targeting of tetracycline-regulatable transgene expression specifically to neuronal and glial cell populations using adenoviral vectors.
Ralph GS; Bienemann A; Harding TC; Hopton M; Henley J; Uney JB
Neuroreport; 2000 Jun; 11(9):2051-5. PubMed ID: 10884069
[TBL] [Abstract][Full Text] [Related]
9. Lack of humoral immune response to the tetracycline (Tet) activator in rats injected intracranially with Tet-off rAAV vectors.
Han Y; Chang QA; Virag T; West NC; George D; Castro MG; Bohn MC
Gene Ther; 2010 May; 17(5):616-25. PubMed ID: 20164859
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study.
Pluta K; Diehl W; Zhang XY; Kutner R; Bialkowska A; Reiser J
BMC Biotechnol; 2007 Jul; 7():41. PubMed ID: 17634114
[TBL] [Abstract][Full Text] [Related]
11. Tetracycline-regulated gene expression in replication-incompetent herpes simplex virus vectors.
Schmeisser F; Donohue M; Weir JP
Hum Gene Ther; 2002 Dec; 13(18):2113-24. PubMed ID: 12542843
[TBL] [Abstract][Full Text] [Related]
12. Development of multigene and regulated lentivirus vectors.
Reiser J; Lai Z; Zhang XY; Brady RO
J Virol; 2000 Nov; 74(22):10589-99. PubMed ID: 11044103
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of adenovirus-mediated tetracycline-controllable expression system.
Mizuguchi H; Hayakawa T
Biochim Biophys Acta; 2001 Nov; 1568(1):21-9. PubMed ID: 11731081
[TBL] [Abstract][Full Text] [Related]
14. Viral vectors based on bidirectional cell-specific mammalian promoters and transcriptional amplification strategy for use in vitro and in vivo.
Liu B; Paton JF; Kasparov S
BMC Biotechnol; 2008 May; 8():49. PubMed ID: 18485188
[TBL] [Abstract][Full Text] [Related]
15. Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness.
Agha-Mohammadi S; O'Malley M; Etemad A; Wang Z; Xiao X; Lotze MT
J Gene Med; 2004 Jul; 6(7):817-28. PubMed ID: 15241789
[TBL] [Abstract][Full Text] [Related]
16. Efficient control of gene expression by a tetracycline-dependent transactivator in single Dictyostelium discoideum cells.
Blaauw M; Linskens MH; van Haastert PJ
Gene; 2000 Jul; 252(1-2):71-82. PubMed ID: 10903439
[TBL] [Abstract][Full Text] [Related]
17. Silencing and un-silencing of tetracycline-controlled genes in neurons.
Zhu P; Aller MI; Baron U; Cambridge S; Bausen M; Herb J; Sawinski J; Cetin A; Osten P; Nelson ML; Kügler S; Seeburg PH; Sprengel R; Hasan MT
PLoS One; 2007 Jun; 2(6):e533. PubMed ID: 17579707
[TBL] [Abstract][Full Text] [Related]
18. An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy.
Sipo I; Hurtado Picó A; Wang X; Eberle J; Petersen I; Weger S; Poller W; Fechner H
J Mol Med (Berl); 2006 Mar; 84(3):215-25. PubMed ID: 16437213
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Tetracycline-regulated Promoters in Lentiviral-based Vectors in Murine Transplantation Studies.
Stahlhut M; Ha TC; Morgan M; Schambach A; Kustikova OS
Curr Gene Ther; 2016; 16(4):242-248. PubMed ID: 27739375
[TBL] [Abstract][Full Text] [Related]
20. Development of single-vector Tet-on inducible systems with high sensitivity to doxycycline.
Chao JS; Chao CC; Chang CL; Chiu YR; Yuan CJ
Mol Biotechnol; 2012 Jul; 51(3):240-6. PubMed ID: 22002194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
